Antipodes Partners awarded

2026 Fund Manager of the Year, Australia

Morningstar Awards 2026 © Morningstar, Inc. All Rights Reserved.

Livewire: Buy Hold Sell – 5 big names reshaping the future and 2 more offering growth

With the ASX struggling to deliver genuine growth, we head offshore to find it. Vihari Ross covers five global names across the US, Korea, Latin America and Europe – plus one high-conviction pick that might surprise you – find out where we see the best opportunities right now.

Transcript

Buy, Hold or Sell – Global Growth Stocks 

I’m Tom and welcome to Livewire’s Buy, Hold, Sell. With the ASX dominated by ex-growth mining and banking stocks and its tech sector decimated by AI, investors might need to look globally for genuine growth. To run the ruler over five global names offering long-term growth potential, I’m joined by Vihari Ross from Antipodes and Casey McClean from Magellan. Guys, thanks for joining us. 

Spotify (NYSE: SPOT) 

We’re going to start with music streaming juggernaut Spotify. It’s up 8% in the last year. Casey, I might come to you first. Buy, hold or sell? 

Spotify’s a buy. We think the valuation looks pretty attractive, but with the big proviso that AI hasn’t changed their growth outlook. If you think about the valuation, it’s trading on around 35 times, which is near its lowest levels. And you’re getting for that a leading music streaming service in a really tightly held oligopoly. Their total addressable market is still pretty untapped and they’re fairly economically insensitive given that 90% of revenue is subscription-based with really low churn, and it pumps out cash flow. They’re sitting on about $10 billion in net cash and investments. 

The risk is around AI and there are probably two big threats. One is that AI enables new disruptive entrants to come into the streaming business. We don’t think that’s likely to play out because creating a streaming service hasn’t really been the barrier to entry in the past, and just having AI coding is not going to change that. The barriers to entry really are how sticky the customers are – you have your music playlists embedded into the platform, and you’re getting a low price with multi-user agreements. Spotify also has really low costs in terms of customer acquisition and retention because they’ve gone out of the app ecosystem – they’re not paying the Apple tax. A new entrant would have to pay that tax as well. So we don’t think that’s likely to pass. 

The other risk is if their total addressable market does actually decline because maybe users leave the platform or they’re not willing to pay up because AI music generation erodes that value. Again, we don’t think that risk is likely to pass given that even AI music creators need to monetise their content, and the best way to do that is through premium tiers on a platform like Spotify. The other way to do that is through advertising models – free music with advertising already exists, Spotify has that option, it’s on the radio as well. So we don’t think that risk is likely to play out either. Given that, we think it’s a buy. 

Fairly comprehensive from Casey. Vihari, what about you? 

Look, I’m a hold on this one, Tom. I think the AI narrative around it is long duration and a little bit beside the point. My issue with it is more its valuation. I think everyone knows what’s good about it – it’s got 750 million monthly active users, it’s got growth in that, it’s able to monetise, etc. I think people often say, “Oh, well, it’s cheap versus its history.” It didn’t used to make money before – it’s only started making money the last couple of years. So using that historical context to anchor the valuation I think is misplaced. 

Essentially you’re paying quite a lot to get access to this decent business, and that makes it very sensitive to bad news. You know, last year the market was disappointed by their results and the stock ended up down 50%. And I think that’s what you’re seeing now – there’s a lot of expectation built into this business, people are paying up for it, and therefore you’re not going to necessarily get the return out of the business that you might be hoping for. 

Amazon (NASDAQ: AMZN) 

Next up we have one of the Magnificent Seven – Amazon. Vihari, I’ll stay with you. Buy or sell? 

Amazon’s a buy. This is a stock that’s actually trading on its lowest multiple relative to its history, in the context of being at a real profit inflection point. For a long time, as the largest cloud player, Amazon was the slowest growing but it was the biggest – growing at around 16–17% per annum. Now, because they’re completely LLM agnostic, there’s been a real step change in AWS growth, getting over 20% growth in AWS with Anthropic and Claude, and Co-work and everything just going off. But then you’ve also got an inflection in the retail side of their business. They’ve been through a big investment phase – they now offer same-day delivery to 100 million people in the US, and as that investment cycle fades, there’s a profit inflection opportunity there. Notwithstanding the advertising opportunity that’s growing at 20% per annum, as fast-moving consumer goods companies start deploying some of that trade spend into Amazon’s grocery channel. Quite like that one – a low multiple and profit inflection to come. 

Like some of the Magnificent Seven, I think Amazon has sold off a bit over the last couple of months. Casey, what about you? 

I think Amazon’s a buy for similar reasons. They are a leading player in the whole AI landscape – their cloud is still growing quite strongly off a very high base. Their Trainium chips are in quite high demand as well. And you can’t forget that they also own a big chunk of Anthropic, who added about $6 billion in annual recurring revenue in February alone – that’s the size of the total revenue pool of some big companies in Australia, and they did that in one month. So I think they’re really quite well placed on the AI and cloud side of things. Then the retail business just continues to tick over, with e-commerce growing mid-teens, advertising mid-20s, margins expanding as they complete out and get better at same-day deliveries, and the valuation looks reasonable to mildly attractive. The risk-reward is overall fairly favourable. 

Samsung (KRX: 005930) 

Another big tech name, this time from Korea – Samsung. Casey, I’ll start with you. Buy, hold or sell? 

Samsung’s a sell. The stock is up two and a half times – 250% – in the last 12 months. And why is that? That’s because memory prices, specifically DRAM, have skyrocketed. They’ve gone up about 200% in the last 6 or 9 months. That’s because there’s been a supply crunch – AI demand for a specific type of DRAM, high bandwidth memory (HBM), has crowded out the traditional demand sources in smartphone and PC. So prices have skyrocketed, as they do because it’s a commodity driven purely by supply and demand. 

But what’s changed is Samsung, along with the other players and Micron, have announced major capital expenditure programs. They’re bringing new supply to market. Historically when they’ve announced these programs, it’s been a pretty good leading indicator that you’re at or near the peak of the cycle. The other thing is those traditional players – the PC and smartphone companies – are really suffering from this. DRAM is about 10–15% of their total material costs, and they’re going to have to pass that on to consumers, and as a result they’re cutting their forecasts for shipments as well. 

So yeah, I think prices could still go higher from here. But the stock usually inflects well before the peak in memory prices. So I think the risk-reward looks really dangerous in Samsung. 

Like Casey said, it’s had a pretty good run – up 250% in the last year. Vihari, what about you? 

Yeah, I disagree. I’m at a hold on this one. We have held it in our emerging markets portfolio. If you think about the excitement around GPU capex spend, what obviously goes hand in glove with that is high bandwidth memory. And what you’ve already seen is that as each of these GPU companies is rolling out higher spec chips, the memory requirement that goes with that is actually also increasing – in just Nvidia’s last two iterations alone, the memory requirement has gone up two and a half times, and that’s going to accelerate again. So there is certainly a cycle in memory – not saying there’s no cycle – but there is an elongated cycle taking place here in memory because of that volume uplift they’re getting. 

Samsung is very much a part of that shift, particularly in HBM4, where they’re getting in on the act now with SK Hynix and Micron. Samsung is trading at two times price to book versus SK Hynix at three times and Micron at five times. The other thing is, because of this hollowing out of the rest of the DRAM memory market, it has left a gap for Samsung, who is actually the dominant player there. They’ve benefited from that pricing advantage as demand for HBM continues. There’s likely to be a gap that Samsung continues to fill. 

Historically also, there’s the foundry business. That’s been a net negative for the valuation. Now, with deploying that foundry in the US, there’s an opportunity for that to be valuation-neutral to slightly positive, particularly as they tap into demand from Apple and Tesla and the like in the US. So we like that one on a hold, and if there’s more negative volatility out of the Korean equity market, it would become a buy. 

MercadoLibre (NASDAQ: MELI) 

Going to look at an emerging market name now – it’s Argentinian e-commerce platform MercadoLibre. Vihari, buy or sell? 

Look, this one is a hold. It’s a business that has incredible growth – an e-commerce platform that’s building out at a rapid clip. But my issue with it is that it’s a business that has been investing a great deal. That’s important – you saw how Amazon did that to great success in the US. They’ve been investing to create a position of dominance, but we don’t know how long that investment cycle is going to carry on. And actually, if you look at it objectively, they’ve got pretty high margins as far as e-commerce retailers go compared to the rest of the world. So the question is at what point will they hit that profit inflection in their business, and how will that be affected by the competitive landscape, notwithstanding the consumer landscape in Brazil. It’s a business that’s well positioned and growing fast – you are paying for that at 30 times – and that profit inflection will sort of justify that multiple, but the timing of it is uncertain. I think it’s down about 10% or so this year. 

Casey, what about you? Buy or sell on MercadoLibre? 

I’m a hold on MercadoLibre as well. I think it’s a really attractive business from a long-term point of view. They’re the largest e-commerce retailer in Latin America. Gross merchandise value is growing at 30% plus – it’s a good mix of user base and frequency of shopping. They have big opportunities in advertising, which is really underpenetrated, and also in banking given their advantages in customer acquisition costs and having all the transaction data. 

But in the shorter term, I’m worried about competition, which is really heating up massively in Latin America – in Brazil in particular – from Amazon and Shopee. Amazon has just launched ultra-fast delivery, 15-minute free delivery for Prime subscribers, and Shopee is moving into higher-value categories and also really improving their logistics network. This is forcing MercadoLibre back into a massive investment program – lowering the threshold for free delivery, doing more first-party, doing more cross-border, and doing more marketing. These are all loss-making initiatives. So even though margins have already stepped down once, the risk is that it’s a much longer and much deeper margin down-cycle than probably the market is expecting. I don’t think you’re being rewarded to take that risk at 30 times. 

Airbus (EPA: AIR) 

Finally, we’re going to cross the Atlantic over to Europe. It’s aerospace company Airbus. Casey, I’ll stay with you. Buy or sell? 

I’m also a hold on Airbus. From a long-term perspective it looks pretty attractive – it’s a really cosy duopoly with them and Boeing. There are no questions about long-term demand. I think there’s a backlog of about 2,000 aircraft from delivery delays that have accumulated since COVID, and they’ve got sort of a 10-year backlog, sitting on a lot of cash as well. The problem is execution has been incredibly poor for a long time now. They’ve got very aggressive plans to ramp up their production rate on the A320s and narrow body aircraft – they’re looking to go to 75 per month, above their previous record of 63 way back in 2019 – and they’ve just had issues on fuselage quality and now engine supply issues as well. Then there’s the A350, the widebody aircraft – they’re doubling their production rate, albeit from a much lower rate, but that’s going to require really good execution on key components like forging and castings, which they’ve had a lot of issues with in the past. At the same time, Boeing is recovering and gaining momentum. They’ve still got hurdles to overcome, but it is improving. So until you can see that execution improve, the market can be very sceptical on the stock. 

Plenty happening. As Casey said there, Vihari, what about you? 

Yeah, Airbus is a buy. It’s a business that has a big structural growth tailwind behind it around leisure travel, particularly in emerging markets. But you’ve also got a big replacement cycle in existing aircraft – they do get old and fuel inefficient, and actually 60% of that order book is replacement of planes. Where it’s really at for Airbus is that the execution challenges have been a function of supply chain constraints. They’ve actually built out the infrastructure base to significantly ramp production. So you might say they’re going to produce more, but that’s because there’s actually significantly more demand, and they’ve already got the expense base locked in for that. As that production is unlocked, there’s going to be a big profit inflection for this stock. Again, you’re paying a discount to its history – it’s a business that’s had a very smooth trajectory over a long period of time prior to the COVID dynamics, which had nothing to do with them and their management capability. 

The other thing is they’ve used Boeing’s woes to create a genuine competitive advantage in narrow body aircraft, which is actually where all the growth is. Wide body is a smaller and less relevant part of the dynamic, and Boeing simply doesn’t have the technology capability that matches Airbus. So you’re seeing – and I’m sure anyone flying around Australia would notice – Airbus incrementally taking significant market share. 

Fair enough. We’ve also asked our guests to bring one global growth name of their own. Vihari, what’s your pick? 

Tencent Holdings (HKG: 0700) 

So my global growth name is Tencent, which is a Chinese essentially utility-like app. This is a business that’s trading at 14 times and growing at 15% plus per annum – even going through a Chinese recession and COVID, they grew their business at 13% per annum. But this is a business that can really benefit from the deployment of AI into their own ecosystem – throughout advertising, their cloud business, their gaming business – all of those AI deployment mechanisms are in train as we speak. Very recently – just a couple of days ago – they’ve also announced Claude Co-work-esque agents as well, and that’s going to prove to be a bit of a catalyst for that business. Again, you’re paying a very undemanding multiple for access to a very nice structural growth stock. 

So Tencent from Vihari. Casey, what have you got for us? 

Alphabet (NASDAQ: GOOG) 

It’s a stock on a similar thematic, and it’s Alphabet, or Google. The stock has re-rated but justifiably so, because we think they’re going to be the biggest winner in the AI era. That’s because they’re the only ones with the full stack to compete. They have the largest user base of any company globally, they have cloud capabilities, they have their own chips for the cloud, a leading model, and importantly the cash flow to fund all of this investment. 

If you drill down on a couple of those – that user base is not just search, where they have 5 billion users. It’s things like YouTube, Maps, and Android, where they’ve got 2–3 billion users. In fact, there are nine products where they have over a billion users. Compare that to ChatGPT, which has 900 million in their one and only app. The ability to use AI across those properties is just tremendous. Even in YouTube, there’s going to be a heap of AI content creation, and when you think about the AI they’re using to improve the recommendation engine, it’s a powerful mix – more content, better recommendations, more engagement, more time spent, and more advertising revenue as a result. 

Then AI chips alone – Google is now on their seventh generation of what they call TPU, or tensor processing unit. They’ve just announced for the first time that they’re going to sell it externally, with a target of generating 10% of Nvidia’s revenue – that’s $30 billion in potential incremental revenue. That looks pretty realistic when you see the benefits these chips give. Nvidia’s GPUs are great – they’re really good at doing a whole range of tasks. What Google has done is shrink that down, and their TPU is really good at just doing AI inferencing. As a result, the cost of inference is half that of using a GPU. You can see it’s fuelling part of their cloud growth – Anthropic has specifically said it’s the price-performance of these chips that attracted them. They’re even selling them externally to companies like Meta as well. This is a company that just continues to compound its earnings and can continue to grow at really strong rates. 

There you have it – some pretty big growth names. Thanks to Casey and Vihari, and thanks for watching. Make sure to check out our YouTube channel for more Buy, Hold, Sell. 

Subscribe to receive the latest news and insights from the Antipodes team

IMPORTANT INFORMATION:
All content in respect of the Antipodes Global Shares (Quoted Managed Fund) (ARSN 625 560 269), the Antipodes Global Fund – Long (ARSN 118 075 764), the Antipodes Global Fund (ARSN 087 719 515), and the Antipodes Emerging Markets (Managed Fund) (ARSN 096 451 393) is issued by Pinnacle Fund Services Limited ABN 29 082 494 371 AFSL 238 371 (“PFSL”) as responsible entity of the Funds and is prepared by Antipodes Partners Limited (ABN 29 602 042 035) (AFSL 481580) (“Antipodes”) as the investment manager of the Trust. PFSL is not licensed to provide financial product advice.
The information provided is of a general nature only and has been prepared without taking into account your objectives, financial situation or needs. Before making an investment decision in respect of the Funds, you should consider the current Product Disclosure Statement (‘PDS’) and Target Market Determination (‘TMD’) of the Funds and the Fund’s other periodic and continuous disclosure announcements lodged with the ASX, which are available at www.asx.com.au, and assess whether the Fund is appropriate given your objectives, financial situation or needs. If you require advice that takes into account your personal circumstances, you should consult a licensed or authorised financial adviser. The Product Disclosure Statement (‘PDS’) and Target Market Determination (‘TMD’) of the relevant Fund are available via below links. Any potential investor should consider the PDS and TMD before deciding whether to acquire, or continue to hold units in, the Fund.
Links to Product Disclosure Statement: IOF0045AU, WHT0057AU, IOF0203AU, WHT3997AU
Links to Target Market Determination: IOF0045AU, WHT0057AU, IOF0203AU, WHT3997AU
For historic TMD’s please contact Pinnacle client service Phone 1300 010 311 or Email service@pinnacleinvestment.com
Neither PFSL nor Antipodes guarantees repayment of capital or any particular rate of return from the Funds. Neither PFSL nor Antipodes gives any representation or warranty as to the currency, reliability, completeness or accuracy of the information contained in this content. All opinions and estimates included in this website constitute judgments of Antipodes as at the date of website creation and are subject to change without notice. Past performance is not a reliable indicator of future performance. Stock commentary is illustrative only, it should not be considered as a recommendation to buy, hold, or sell any security. 

Share:

More Posts

Now available on the ASX: the Antipodes Global SMID Active ETF (ASX:MIDS)

X